Literature DB >> 6385227

Acute and long-term complications of corticosteroid pulse therapy.

F A Wollheim.   

Abstract

Complications caused by pulse therapy (PT) using "suprapharmacological" doses of methylprednisolone (MP) are reviewed. The reported adverse effects vary between 0 and 56% in different series. More intense and prolonged PT seems to result in higher toxicity. An improvement in therapeutic index for PT over oral corticosteroids has been found in two out of three controlled studies on renal transplant rejection. No controlled studies of PT in SLE have been published. Neuropsychiatric reactions occur in both SLE and RA.

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6385227     DOI： 10.3109/03009748409103858

Source DB:  PubMed          Journal:  Scand J Rheumatol Suppl        ISSN： 0301-3847


  12 in total

1.  New-onset acute heart failure after intravenous glucocorticoid pulse therapy in a patient with Graves' ophthalmopathy.

Authors:  Alptekin Gursoy; Mustafa Cesur; Murat Faik Erdogan; Demet Corapcioglu; Nuri Kamel
Journal:  Endocrine       Date:  2006-06       Impact factor: 3.633

2.  Case report 554: Osteonecrosis at multiple sites as noted.

Authors:  A G Archer; M C Nelson; S L Abbondanzo; G P Bogumill
Journal:  Skeletal Radiol       Date:  1989       Impact factor: 2.199

3.  Immunological treatment of multiple sclerosis. II.

Authors:  R A Hughes
Journal:  J Neurol       Date:  1986-04       Impact factor: 4.849

4.  First report of supraventricular tachycardia after intravenous pulse methylprednisolone therapy, with a brief review of the literature.

Authors:  Rakesh Kumari; S S Uppal
Journal:  Rheumatol Int       Date:  2005-02-23       Impact factor: 2.631

5.  Use of Single- or Two-dose Pulse Methylprednisolone in the Treatment of Acute Immune Thrombocytopenic Purpura.

Authors:  Ayşe Bozkurt Turhan; Zeynep Canan Özdemir; Özcan Bör
Journal:  Sisli Etfal Hastan Tip Bul       Date:  2018-03-21

Review 6.  Corticosteroid-induced neuropsychiatric disorders: review and contrast with neuropsychiatric lupus.

Authors:  Samir D Bhangle; Neil Kramer; Elliot D Rosenstein
Journal:  Rheumatol Int       Date:  2013-04-16       Impact factor: 2.631

7.  Novel therapy of focal glomerulosclerosis with mycophenolate and angiotensin blockade.

Authors:  Brenda Montané; Carolyn Abitbol; Jayanthi Chandar; José Strauss; Gastón Zilleruelo
Journal:  Pediatr Nephrol       Date:  2003-06-13       Impact factor: 3.714

8.  [Medicinal prophylaxis during intensified immunosuppression in children and adolescents : part 2].

Authors:  F Speth; N Wellinghausen; J-P Haas
Journal:  Z Rheumatol       Date:  2013-11       Impact factor: 1.372

9.  Survey of the long term incidence of osteonecrosis of the hip and adverse medical events in rheumatoid arthritis after high dose intravenous methylprednisolone.

Authors:  I A Williams; A D Mitchell; W Rothman; P Tallett; K Williams; P Pitt
Journal:  Ann Rheum Dis       Date:  1988-11       Impact factor: 19.103

10.  Follow-up on pediatric patients with bronchiolitis obliterans treated with corticosteroid pulse therapy.

Authors:  Silvia Onoda Tomikawa; Fabíola Villac Adde; Luiz Vicente Ribeiro Ferreira da Silva Filho; Claudio Leone; Joaquim Carlos Rodrigues
Journal:  Orphanet J Rare Dis       Date:  2014-08-15       Impact factor: 4.123
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.